Vapotherm (NYSE:VAPO – Get Rating) had its price objective reduced by equities researchers at Piper Sandler from $5.00 to $2.50 in a research note issued on Thursday, The Fly reports. Piper Sandler’s price target points to a potential downside of 15.25% from the stock’s previous close. VAPO has been the subject of a number of […]
Vapotherm, Inc. (NYSE:VAPO – Get Rating) CFO John Landry bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 24th. The shares were purchased at an average cost of $2.90 per share, for a total transaction of $14,500.00. Following the transaction, the chief financial officer now owns 128,074 shares in the company, […]
Vapotherm (NYSE:VAPO – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for the treatment of chronic lung and acute breathing disorders. The Company […]
Vapotherm, Inc. (NYSE:NYSE:VAPO) Q1 2022 Earnings Conference Call May 04, 2022, 16:30 ET Company Participants Mark Klausner - Westwicke Partners Joseph Army - CEO, President & Director.
Zacks Investment Research upgraded shares of Vapotherm (NYSE:VAPO – Get Rating) from a hold rating to a buy rating in a research report report published on Wednesday, Zacks.com reports. They currently have $5.25 price target on the stock. According to Zacks, “Vapotherm Inc. is a medical technology company. It designs and develops respiratory devices for […]